BioCentury
ARTICLE | Company News

Daiichi Sankyo, Mitsubishi Tanabe Pharma sales and marketing update

September 22, 2014 7:00 AM UTC

Mitsubishi and Daiichi launched Canaglu canagliflozin in Japan to treat Type II diabetes. In 2012, Mitsubishi partnered with Daiichi Sankyo to co-commercialize canagliflozin in Japan. Canagliflozin i...